Pharmakoepidemiologische Auswertungen des DAPI

Home Publications

About the Authors

Years

Clear selection

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

...

Authors

Clear selection

Abdin A

Andresen-Streichert H

Barcina Lacosta T

Bartmeyer B

Baumgarten A

Böhm M

Böhm R

Botermann L

Bruckmüller H

Burkart M

Czeche S

Diener F

Dippel FW

Enners S

Feldt S

Franzmann A

Freudewald LG

Friedland K

Friis R

Ganso M

Goebel R

Götzinger F

Gradl G

Griese-Mammen N

Hadji P

von Haehling S

Haidinger G

Hansen K

Heinemann A

Hengstler-Stahl S

Herdegen T

Hofmann GA

Huys I

Iliescu OC

Iwersen-Bergmann S

Jacobs CM

Katzmann JL

Kerwagen F

Kieble M

Kintscher U

Klein HJ

Klöckner D

Kloft C

von Klot S

Kollan C

Krieg EM

Kroemer HK

Krüger K

Kugler J

Kuhn K

Kunz M

Lang BM

Lauder L

Laufs U

Leuner K

Ludwig WD

Mahfoud F

Mauss S

Meyer MR

Millenaar D

Möhrke W

Moorkens E

Müller A

Müller U

Müller WE

Nagaba J

Ochmann S

Peveling-Oberhag A

Pöhlau D

Quinzler R

Resch KH

Riemer U

Rudolph UM

Rüsenberg R

Said A

Salzmann S

Schmidt D

Schmitz N

Schönfeld T

Schubert I

Schulz M

Schüssel K

Selke GW

Simoens S

Staubach-Renz P

Störk S

Tanew A

Teichert M

Ude M

Ukena C

Verdenhalven C

Vulto AG

Wachter R

Weber B

Werning J

Weyer V

Ziller V

Zimmer S

...

Deutsch Englisch

Contact Impressum Nutzung Data Protection Login

Home Publications

About the Authors

Deutsch Englisch

Contact Impressum Nutzung Data Protection Login

Impact of rebate contract legislation on generic substitution of valproate – a retrospective study of ambulatory drug dispensing in the DAPI database

Incidence of thyroid hormone therapy in patients treated with sorafenib or sunitinib

Effect of generic switch on pharmacy refill compliance after ramipril patent expiry – a retrospective study using the DAPI database

Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.

Comparison of different ways of calculation (DDD vs. SPC) to determine persistence and compliance with beta blockers in the DAPI database.

Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database.

Association between generic substitution of valproate and therapeutic modification of antiepileptic therapy – a cohort study with time-dependent exposure utilizing the DAPI ambulatory drug claims data

1 2 3 4 5 6 7

More Publications

Pharmakoepidemiologische Auswertungen des DAPI

AMINO-Jahrestagung der Apothekerkammer Berlin

Conflicts of interests: none declared